Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Myeloproliferative Neoplasms (MF – PV – ET)
January 24, 2021
Imetelstat for Myelofibrosis
Dr. C H Weaver MD
November 7, 2020
Overview of Myeloproliferative Neoplasms
Dr. C H Weaver MD
October 2, 2020
Budd-Chiari Syndrome
Dr. C H Weaver MD
April 15, 2020
Jakafi Superior to Standard Therapy for Polycythemia Vera
Dr. C H Weaver MD
January 24, 2020
Understanding Allogeneic Stem Cell Transplant
Dr. C H Weaver MD
December 30, 2019
Inrebic (fedratinib) Treatment of Myelofibrosis
Dr. C H Weaver MD
December 27, 2019
Progress on Pacritinib Development for Treatment of Myelofibrosis
Dr. C H Weaver MD
September 17, 2019
Ojjaara (momelotinib) Gets FDA Approval for Myelofibrosis
Dr. C H Weaver MD
September 5, 2018
What you Need to Know about Itching and Myeloproliferative Neoplasms
Dr. C H Weaver MD
December 29, 2015
Symptomatic Polycythemia Vera Patients May Benefit From Treatment
Dr. C H Weaver MD
Previous Page
1
2
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
